SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?


To: Tomato who wrote (269)9/23/2000 12:14:37 AM
From: RCMac  Respond to of 1833
 
>> When you add the royalty stream and the stock held in Axiom to the equation, how much do you get as a value per share? <<

See this post two weeks ago:
Message 14344049

And for Rick on the potential royalty stream, see, for example, ## 268 and 63 on this thread. Even better, maybe read the whole thread?



To: Tomato who wrote (269)9/23/2000 1:20:22 PM
From: scaram(o)uche  Read Replies (2) | Respond to of 1833
 
>> I'd buy more, but I'm a little leery of the illiquidity. <<

Me too. So were others at $0.15, before it popped to over $5/share. I got shares, in the past 12 months, at 1/16.

Do I know why it should have gone to $5? No. Do I understand why it should have come back under $2? No.

So... people were afraid of the lack of liquidity at $0.15. Recently, they were afraid, for a long time, of the lack of liquidity at $0.65 -- and then it took back $1.50.

One need go with conviction. I did not sell a single share into the recent rally or since then. I have added slightly to my **modest** position.